GJB7 Antibody

What is GJB7 and why is it important in cellular studies?

GJB7 (Gap Junction Beta-7 protein), also known as Connexin-25 (Cx25), is a connexin protein involved in forming gap junctions between cells. Connexins such as GJB7 are involved in the formation of gap junctions, which are intercellular conduits that directly connect the cytoplasms of contacting cells. Each gap junction channel is formed by docking of 2 hemichannels, each containing 6 connexin subunits . This protein plays a critical role in cell-to-cell communication by allowing the passage of small molecules and signals between adjacent cells.

The study of GJB7 is particularly important in:

• Cell signaling research

• Understanding intercellular communication mechanisms

• Investigating tissue homeostasis

• Studying pathological conditions where cellular communication is disrupted

Recent research indicates that some gap junction proteins, including GJB7, show copy number variations in certain cancer types, suggesting potential roles in carcinogenesis .

What applications are GJB7 antibodies commonly used for in research?

GJB7 antibodies are versatile tools that can be employed in multiple experimental techniques:

Most commercially available GJB7 antibodies are rabbit polyclonal antibodies that react with human GJB7 . When designing experiments, researchers should verify the antibody's validated applications, as not all antibodies perform equally across different techniques. For example, the antibody described in search result has been specifically validated for WB and ELISA applications, showing positive results in Western blot analysis of lysates from HeLa cells.

How should GJB7 antibody specificity be validated?

Validating antibody specificity is critical for obtaining reliable research results. For GJB7 antibodies, consider implementing these validation strategies:

• Positive controls: Use cells or tissues known to express GJB7, such as HeLa cells, which have been successfully used in Western blot validation studies .

• Molecular weight verification: Confirm that the antibody detects a protein of the expected molecular weight (approximately 25-26 kDa for GJB7) .

• Peptide competition assays: Pre-incubate the antibody with the immunizing peptide. Many GJB7 antibodies are generated using synthetic peptides derived from human GJB7, often from specific regions (amino acids 4-53 or internal regions) .

• Knockdown/knockout validation: Compare antibody reactivity in wild-type versus GJB7-depleted samples.

• Cross-reactivity assessment: Test the antibody against other connexin family members to ensure specificity for GJB7.

Many commercially available GJB7 antibodies have undergone specific validation processes. For example, the antibody described in search result is "purified from rabbit serum by antigen affinity chromatography using the immunizing peptide," which enhances its specificity for the target protein.

What are the optimal storage and handling conditions for GJB7 antibodies?

Proper storage and handling of GJB7 antibodies is essential for maintaining their activity and specificity:

• Storage temperature: Store at -20°C for long-term storage. Some suppliers recommend avoiding freeze/thaw cycles .

• Shipping condition: Antibodies are typically shipped at 4°C .

• Aliquoting: Upon receipt, aliquot the antibody into smaller volumes to avoid repeated freeze/thaw cycles.

• Buffer composition: Most GJB7 antibodies are supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, with 150mM NaCl, 0.02% sodium azide, and 50% glycerol .

• Working dilution preparation: When preparing working dilutions, use fresh, sterile buffers and handle the antibody on ice.

According to product specifications, some GJB7 antibodies can be stored at 2-8°C for up to 2 weeks for short-term use , but long-term storage at -20°C is recommended for maintaining optimal activity.

What controls should be included when using GJB7 antibodies?

Including appropriate controls is critical for interpreting results obtained with GJB7 antibodies:

• Positive tissue/cell controls: Use samples known to express GJB7. HeLa cells have been documented as expressing detectable levels of GJB7 by Western blot .

• Negative controls: Include tissues or cell lines that do not express GJB7.

• Isotype controls: Use isotype-matched non-specific antibodies (e.g., Rabbit IgG) to assess non-specific binding. Specific isotype controls are often recommended by antibody manufacturers, such as Rabbit IgG controls A82272 or A17360 .

• Secondary antibody controls: Perform staining with only the secondary antibody to check for non-specific binding. Suitable secondary antibodies include goat anti-rabbit IgG antibodies conjugated with AP, biotin, FITC, or HRP .

• Peptide blocking controls: Pre-incubate the antibody with its immunizing peptide to confirm specificity.

For quantitative analyses, include a standard curve with recombinant GJB7 protein when possible. Some manufacturers offer recombinant GJB7 proteins specifically for this purpose .

How can GJB7 antibodies be applied in cancer research?

GJB7 has emerging relevance in cancer research, with implications for both diagnostic and mechanistic studies:

• Copy number variations: GJB7 has been found to be deleted in prostate cancer (PRAD) with copy number variation in more than 5% of samples . Despite these genomic alterations, GJB7 is not expressed in several cancer types, suggesting complex regulatory mechanisms.

• Frameshift mutations: GJB7 has been found to harbor frameshift mutations in colorectal cancer with microsatellite instability. Specifically, one colorectal cancer sample (1%) with high microsatellite instability (MSI-H) showed a GJB7 frameshift mutation .

• Methodological approaches:

  • Use GJB7 antibodies for tissue microarray analysis across different cancer types

  • Investigate GJB7 expression in relation to tumor stage and grade

  • Examine correlations between GJB7 expression and patient outcomes

  • Study GJB7 in the context of other connexins that have established roles in cancer

• Intratumoral heterogeneity: When studying GJB7 in cancer, consider potential regional intratumoral heterogeneity (ITH), which has been observed for mutations in other connexin genes .

Recent research indicates that "frameshift mutations of tight junction and gap junction genes might contribute to tumorigenesis by altering their functions in gastric and colorectal cancer" , making GJB7 a potentially relevant target for further investigation in cancer biology.

What are the technical considerations for using GJB7 antibodies in co-immunoprecipitation studies?

Co-immunoprecipitation (Co-IP) with GJB7 antibodies presents several technical challenges due to GJB7's membrane localization and structural properties:

• Lysis buffer selection: Use mild detergents (0.5-1% NP-40, Triton X-100, or digitonin) to solubilize membrane proteins while preserving protein-protein interactions.

• Cross-linking considerations: Consider using membrane-permeable cross-linkers (e.g., DSP or formaldehyde) before lysis to stabilize transient interactions.

• Antibody selection: Choose antibodies specifically validated for immunoprecipitation. Not all GJB7 antibodies will work effectively for Co-IP.

• Bead selection: Protein A or G beads should be selected based on the antibody's host species and isotype (Protein A for rabbit IgG).

• Pre-clearing lysates: Pre-clear cell lysates with beads alone to reduce non-specific binding.

• Controls:

  • IgG control: Use non-specific IgG from the same species as the GJB7 antibody

  • Input control: Save a portion of the pre-IP lysate to confirm target protein presence

  • Reverse Co-IP: If possible, immunoprecipitate with antibodies against suspected interacting proteins and probe for GJB7

• Washing conditions: Optimize washing stringency to remove non-specific interactions while preserving specific ones.

• Elution methods: Consider native elution with competing peptides if downstream functional assays are planned.

These technical considerations are particularly important when studying GJB7's interactions with other connexins or junction-associated proteins.

How can quantitative analysis of GJB7 expression be performed using antibody-based techniques?

Quantitative analysis of GJB7 expression requires careful consideration of methodological approaches and controls:

• Western blot quantification:

  • Use a standard curve with recombinant GJB7 protein for absolute quantification

  • Include loading controls (β-actin, GAPDH) for relative quantification

  • Apply densitometric analysis using software such as ImageJ

  • Use appropriate statistical methods for comparing expression levels

• Quantitative ELISA:

  • Commercial GJB7 antibodies have been validated for ELISA applications with recommended dilutions of 1:10000

  • Develop standard curves using recombinant GJB7 protein

  • Include technical and biological replicates

  • Consider sandwich ELISA approaches for improved specificity

• Flow cytometry:

  • Optimize fixation and permeabilization protocols for intracellular GJB7 detection

  • Use fluorochrome-conjugated secondary antibodies with appropriate controls

  • Employ quantitative fluorescence standards for calibration

  • Report results as median fluorescence intensity or molecules of equivalent soluble fluorochrome

• Quantitative immunofluorescence:

  • Use consistent image acquisition parameters

  • Include fluorescence standards in each imaging session

  • Apply appropriate background subtraction methods

  • Consider automated image analysis software for unbiased quantification

• Digital pathology approaches:

  • Use slide scanners for whole-slide imaging

  • Apply color deconvolution for DAB-stained sections

  • Perform automated scoring of staining intensity and distribution

  • Validate computer-assisted measurements against pathologist scoring

For all quantitative approaches, validation with orthogonal methods (e.g., qPCR for mRNA levels) is recommended to strengthen confidence in protein expression measurements.

What strategies can be used for studying GJB7 in relation to other connexin family members?

Studying GJB7 in relation to other connexin family members requires careful experimental design:

• Multiplex immunostaining approaches:

  • Use antibodies raised in different host species

  • Employ sequential staining protocols with careful blocking steps

  • Consider tyramide signal amplification for detecting low-abundance connexins

  • Use spectral imaging to separate closely overlapping fluorescent signals

• Co-expression analysis:

  • Perform dual immunolabeling to assess co-localization of GJB7 with other connexins

  • Use confocal or super-resolution microscopy for detailed co-localization studies

  • Apply appropriate co-localization analysis methods (Pearson's correlation, Manders' coefficients)

• Functional studies:

  • Design knockdown/knockout experiments targeting GJB7 while monitoring other connexins

  • Investigate potential compensatory mechanisms among connexin family members

  • Perform gap junction dye transfer assays to assess functional coupling

• Heteromeric/heterotypic channel investigation:

  • Use proximity ligation assays to detect closely associated connexin proteins

  • Employ FRET-based approaches to study direct interactions

  • Combine with electrophysiological techniques to assess channel properties

These approaches can help elucidate the specific contributions of GJB7 to gap junction function in the context of the broader connexin family, which includes over 20 members in humans with diverse tissue expression patterns and functional properties.

How can GJB7 antibodies be used in conjunction with recombinant protein studies?

Integrating GJB7 antibodies with recombinant protein approaches offers powerful strategies for functional and structural studies:

• Recombinant protein validation:

  • Use GJB7 antibodies to confirm successful expression of recombinant GJB7 proteins

  • Compare immunoreactivity of recombinant and native GJB7 to verify proper folding

  • Recombinant GJB7 proteins with Strep tags are available for research use

• Structure-function relationship studies:

  • Generate point mutations or truncations in recombinant GJB7

  • Use antibodies to assess protein expression and localization of mutant forms

  • Map epitope regions recognized by different antibodies

  • The full sequence of human GJB7 (AA 1-223) is available and can be used for designing recombinant constructs

• Antibody epitope mapping:

  • Generate overlapping peptide fragments of GJB7

  • Use antibody binding assays to identify specific epitopes

  • This information can help interpret results when studying naturally occurring GJB7 variants

• In vitro channel reconstitution:

  • Incorporate recombinant GJB7 into liposomes or planar lipid bilayers

  • Use antibodies to confirm incorporation and orientation

  • Apply antibodies to modulate channel function in reconstituted systems

• Antibody engineering:

  • Recent advances in antibody design and selection techniques can be applied to generate GJB7 antibodies with customized specificity profiles

  • Computational approaches can help predict antibody binding to specific GJB7 epitopes

When working with recombinant GJB7 protein, it's important to note that the protein is typically supplied in liquid form and may require specific buffer conditions for optimal stability and functionality .

What are the methodological considerations for studying GJB7 mutations using antibody-based techniques?

Investigating GJB7 mutations requires careful consideration of antibody selection and experimental design:

• Epitope accessibility:

  • Consider whether mutations might affect the epitope recognized by the antibody

  • Use multiple antibodies targeting different regions of GJB7 to ensure detection of mutant forms

  • For frameshift mutations (as identified in colorectal cancer ), use antibodies targeting regions upstream of the mutation site

• Expression level assessment:

  • Compare GJB7 expression levels between wild-type and mutant samples using quantitative approaches

  • Consider whether mutations affect protein stability or turnover rates

• Subcellular localization:

  • Investigate whether mutations alter GJB7 trafficking or membrane incorporation

  • Use confocal microscopy to examine co-localization with organelle markers

  • Compare plasma membrane versus intracellular distribution of wild-type and mutant GJB7

• Functional correlation:

  • Combine antibody staining with functional assays (e.g., dye transfer, electrophysiology)

  • Examine whether mutation-induced changes in localization correlate with functional defects

• Context-specific effects:

  • Study mutations in appropriate cellular contexts that mimic the pathological condition

  • Consider tissue-specific factors that might influence mutant GJB7 behavior

• Controls and validation:

  • Use artificially introduced mutations as controls when studying naturally occurring variants

  • Validate antibody recognition of mutant forms using overexpression systems

These methodological considerations are particularly relevant given the identification of GJB7 frameshift mutations in colorectal cancer with microsatellite instability , suggesting potential pathogenic roles for GJB7 alterations.

What specialized techniques can be used to study GJB7 in tissues and organoids?

Advanced techniques for studying GJB7 in tissues and three-dimensional culture systems offer insights into connexin biology in more physiologically relevant contexts:

• Tissue clearing and 3D imaging:

  • Apply CLARITY, iDISCO, or other tissue clearing methods for whole-mount GJB7 immunostaining

  • Use light-sheet microscopy for rapid 3D imaging of large tissue volumes

  • Perform computational analysis of gap junction distribution in three dimensions

• Multiplex immunohistochemistry:

  • Combine GJB7 staining with markers of cell type, cell state, and tissue architecture

  • Use cyclic immunofluorescence or sequential immunoperoxidase staining

  • Apply multispectral imaging for separating closely related signals

• In situ proximity ligation assay (PLA):

  • Detect protein-protein interactions involving GJB7 in tissue sections

  • Visualize close associations between GJB7 and other connexins or junction proteins

  • Combine with standard immunofluorescence for contextual information

• Organoid applications:

  • Study GJB7 expression and localization during organoid development

  • Examine the effects of GJB7 knockdown/knockout on organoid formation and function

  • Investigate cell-cell communication in organoids derived from normal versus diseased tissues

• Correlative light and electron microscopy (CLEM):

  • Identify GJB7-positive structures by immunofluorescence

  • Examine the same structures at ultrastructural level by electron microscopy

  • Verify gap junction plaque formation and structure

These advanced techniques can provide insights into GJB7 function in complex multicellular environments, offering advantages over traditional 2D cell culture systems for understanding physiological and pathological roles of gap junctions.